Apontis Pharma AG
XETRA:APPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apontis Pharma AG
XETRA:APPH
|
DE |
|
Fujikura Composites Inc
TSE:5121
|
JP |
|
S
|
Sanyu Construction Co Ltd
TSE:1841
|
JP |
|
IntegraFin Holdings plc
LSE:IHP
|
UK |
|
D
|
Dayang Enterprise Holdings Bhd
KLSE:DAYANG
|
MY |
|
Clearwater Paper Corp
NYSE:CLW
|
US |
|
Glatfelter Corp
NYSE:GLT
|
US |
|
Bros Eastern Co Ltd
SSE:601339
|
CN |
|
Shanghai International Airport Co Ltd
SSE:600009
|
CN |
|
A
|
ANE (Cayman) Inc
HKEX:9956
|
CN |
|
Xpeng Inc
NYSE:XPEV
|
CN |
|
SJVN Ltd
NSE:SJVN
|
IN |
Apontis Pharma AG
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.